SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lim, Soyoung ^a   Becker, Astrid ^b   Zimmer, Andreas ^b   Lu, Jianrong ^c   Buettner, Reinhard ^a   Kirfel, Jutta ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD24 ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; STAT2 PROTEIN; STAT3 PROTEIN; T CELL FACTOR PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; WNT5A PROTEIN;

ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL ACTIVATION; CELL DEATH; CELL POPULATION; COLONY FORMATION; CONTROLLED STUDY; DNA DAMAGE; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE ACTIVATED CELL SORTING; GENE CONTROL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PLASTICITY; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; UPREGULATION;

CELL DEATH; CELL LINE, TUMOR; CYTOKINES; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

GASTROPODA;

EID: 84879171839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066558     Document Type: Article

References (41)

1. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, et al. (2008) Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68: 937-945.
2. Gavert N, Ben-Ze'ev A, (2008) Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14: 199-209.
3. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
4. Dreesen O, Brivanlou AH, (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3: 7-17.
5. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, et al. (2006) The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15: 1894-1913.
6. Shostak K, Chariot A, (2011) NF-kappaB, stem cells and breast cancer: the links get stronger. Breast Cancer Res 13: 214.
7. Fuxe J, Vincent T, Garcia de Herreros A, (2010) Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 9: 2363-2374.
8. Ashburner BP, Westerheide SD, Baldwin AS Jr, (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21: 7065-7077.
9. Maugeri-Sacca M, Vigneri P, De Maria R, (2011) Cancer stem cells and chemosensitivity. Clin Cancer Res 17: 4942-4947.
10. Li L, Bhatia R, (2011) Stem cell quiescence. Clin Cancer Res 17: 4936-4941.
11. Lin T, Ponn A, Hu X, Law BK, Lu J, (2010) Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29: 4896-4904.
12. Lim S, Janzer A, Becker A, Zimmer A, Schule R, et al. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31: 512-520.
13. Park SA, Na HK, Kim EH, Cha YN, Surh YJ, (2009) 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res 69: 2416-2424.
14. Schulte JH, Lim S, Schramm A, Friedrichs N, Koster J, et al. (2009) Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 69: 2065-2071.
15. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, et al. (2004) Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18: 1131-1143.
16. Al-Hajj M, Clarke MF, (2004) Self-renewal and solid tumor stem cells. Oncogene 23: 7274-7282.
17. Ricardo S, Vieira AF, Gerhard R, Leitao D, Pinto R, et al. (2011) Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 64: 937-946.
18. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, et al. (2004) Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6: R605-615.
19. Kooreman NG, Wu JC, (2010) Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface 7Suppl 6: S753-763.
20. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, et al. (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 104: 16158-16163.
21. Katoh M, (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045.
22. Tse JC, Kalluri R, (2007) Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101: 816-829.
23. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, et al. (2002) Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156: 299-313.
24. Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, et al. (2009) Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059-2068.
25. Scheel C, Weinberg RA, (2012) Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Semin Cancer Biol 22: 396-403.
26. Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, et al. (2009) Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol 7: e1000121.
27. Iliopoulos D, Hirsch HA, Struhl K, (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
28. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K, (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39: 493-506.
29. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071.
30. Korkaya H, Liu S, Wicha MS, (2011) Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin Cancer Res 17: 6125-6129.
31. Bromberg J, Wang TC, (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15: 79-80.
32. Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, et al. (2007) p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells 25: 807-815.
33. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, et al. (2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117: 3988-4002.
34. Sethi N, Dai X, Winter CG, Kang Y, (2011) Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 19: 192-205.
35. Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, et al. (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120: 485-497.
36. Pantschenko AG, Pushkar I, Anderson KH, Wang Y, Miller LJ, et al. (2003) The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 23: 269-284.
37. Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, et al. (2004) Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10: 7157-7162.
38. Bierie B, Moses HL, (2009) Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8: 3319-3327.
39. Singh A, Settleman J, (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
40. Serra R, Easter SL, Jiang W, Baxley SE, (2011) Wnt5a as an effector of TGFbeta in mammary development and cancer. J Mammary Gland Biol Neoplasia 16: 157-167.
41. Katoh M, (2009) Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int J Mol Med 23: 763-769.